90 minute live webinar
14:00 (UK/London Time Zone)
27 Jan 2021
The UK has left the EU, and the transition period has now ended. This will have major implications for all aspects of Medicines Regulations in the UK.
During this 90 minute webinar, our expert speaker Dr David Jefferys will talk about the implications and the new opportunities that will arise, including:
The webinar will include a 45 minute presentation, followed by a discussion and Q&A session.
David Jefferys (More...)
Dr David Jefferys is Senior Vice President for Global Regulatory, Government Relations, Public Affairs and Patient Safety (EMEA, Russia and Australasia) at Eisai. After qualifying, he worked in clinical and academic medicine before spending 20 years as a senior regulator for both medicines and medical devices.
He was executive director of the UK Medicines Control Agency, CEO and Director of the MDA and joint CEO of the MHRA. He was involved in the establishment of the European Medicines Agency, is a CPMP/CHMP member and Chair of the MRFG and PER scheme. For the last ten years he has worked in industry and chairs several key committees for ABPI,EFPIA and IFPMA.
27 Jan 2021 Live webinar |
|||
27 Jan 2021 Live webinar |
GBP 99.00 EUR 139.00 USD 154.00 + VAT @ 20.00% |
Enrol now
to attend Live webinar |
|
Learn more about our face-to-face and webinar training formats.